By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
ScienceabodeScienceabode
  • Home
  • News & Perspective
    News & PerspectiveShow More
    Microorganism that causes rare but severe eye infections detected in NSW coastal areas
    By Admin
    Scientists identify common cause of gastro in young children and adults over 50 years old
    By admin
    AI reveals hidden traits about our planet’s flora to help save species
    By admin
    Eye drops slow nearsightedness progression in kids, study finds
    By admin
    Using AI to create better, more potent medicines
    By admin
  • Latest News
    Latest NewsShow More
    Researchers develop new robot medics for places doctors are unable to be
    By Admin
    Even thinking about marriage gets young people to straighten up
    By admin
    Study: People tend to locate the self in the brain or the heart – and it affects their judgments and decisions
    By admin
    UCLA patient is first to receive successful heart transplant after using experimental 50cc Total Artificial Heart
    By admin
    Via Dying Cells, UVA Finds Potential Way to Control Cholesterol Levels
    By admin
  • Health
    Health
    The World Health Organization defines health as “a state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity.”…
    Show More
    Top News
    World’s largest study of brain volume reveals genetic links to ADHD, Parkinson’s Disease 
    October 26, 2024
    Chemicals produced by fires show potential to raise cancer risk
    November 11, 2024
    Rising rates of head and neck cancers in England
    October 26, 2024
    Latest News
    Game-Changer in Emergency Medicine: New AI Test Flags Sepsis Hours Before Symptoms Worsen
    June 4, 2025
    Perfumes and lotions disrupt how body protects itself from indoor air pollutants
    June 3, 2025
    Medical Milestone: Surgeons Perform First-Ever Human Bladder Transplant
    May 20, 2025
    A Downside of Taurine: It Drives Leukemia Growth
    May 19, 2025
  • Environment
    EnvironmentShow More
    Perfumes and lotions disrupt how body protects itself from indoor air pollutants
    By Admin
    Arsenic exposure linked to faster onset of diabetes in south Texas population 
    By Admin
    Antarctica vulnerable to invasive species hitching rides on plastic and organic debris
    By Admin
    New substrate material for flexible electronics could help combat e-waste
    By Admin
    Bacteria ‘nanowires’ could help scientists develop green electronics
    By Admin
  • Infomation
    • Pricavy Policy
    • Terms of Service
  • Jobs
  • Application Submission
Notification Show More
Aa
ScienceabodeScienceabode
Aa
  • Home
  • Health
  • Anatomy
  • Jobs Portal
  • Application Submission
  • Categories
    • Health
    • Anatomy
    • Food & Diet
    • Beauty Lab
    • News & Perspective
    • Environment
  • More Foxiz
    • Blog Index
    • Sitemap
Follow US
Scienceabode > Blog > Latest News > Psoriasis patients have reduced access to efficient treatment method with age
Latest News

Psoriasis patients have reduced access to efficient treatment method with age

admin
Last updated: 2016/04/21 at 3:29 PM
By admin
Share
4 Min Read
SHARE

thumb


Marcus Schmitt-Egenolf, professor of dermatology and venereology at Umeå University. Credit: Mattias Pettersson

 

A new study from Umeå University shows that age plays a huge role when it comes to patients’ access to psoriasis treatment. Researchers who have examined if patients of varying ages have the same access to the most efficient psoriasis treatment, found that an age increase of 30 years resulted in an average 65 per cent reduction in likelihood of obtaining treatment with biologics. The study is described in an article published in the British Journal of Dermatology.

- Advertisement -
MedBanner_Skyscraper_160x600_03/2018

A group of researchers led by Marcus Schmitt-Egenolf at Umeå University has, in a cohort study, investigated the effects of ageing in terms of access to modern pharmaceuticals in psoriasis healthcare. The study, which is the first of its kind, found that elderly patients have reduced access to the relatively new treatment of psoriasis using biologics. Biologics are medications that either target T-cells or block immune system protein and is more efficient but also more expensive than the corresponding, conventional and systematic treatment. The study shows that the patient’s access to this treatment method was reduced with every year of ageing.

“This result indicates that there are huge differences in access of treatments with biologics between patients who seem the same in all other aspects apart from age,” says Marcus Schmitt-Egenolf, professor of dermatology at the Department of Public Health and Clinical Medicine at Umeå University and senior author of the article.

“The differences are becoming increasingly clear if you compare a mother to her daughter and supposes that there is a 30-year age difference. The chances for the mother to start a treatment with biologics are then a third in comparison to the daughter and the only reason for this is her age.”

The unequal access to the treatment method shows that improvements are needed in order to reduce the inequality in clinical praxis. Further research is needed to investigate how much of this is affected by the patient’s own choice.

By analysing health data from 1,465 patients with psoriasis, researchers involved in the study have been able to use a model which measured what effect ageing had on the probability of starting a treatment with biologics. The study took into account variables such as gender, BMI, comorbidity (having other illnesses than psoriasis), assessed severity of psoriasis, and the educational level of the patient. These variables are known to affect prescription of biologics and were chosen to enable researchers to objectively assess the effects of age alone.

Psoriasis is a long-lasting autoimmune disease characterised by patches of abnormal skin. It affects around 2–4 per cent of the population. In contrast to mild psoriasis, which can be treated with creams. Patients with moderate to severe psoriasis often need regular and systematic treatment, and many of these patients start treatment with biologics when other medicines show no effect. The first treatment with biologics, which in general either targets T-cells or block immune system protein, was approved for psoriasis treatment in Sweden in 2004. Its medications are highly efficient, but expensive.

Source: Umeå University.

Published on 27th January 2016

admin April 21, 2016 April 21, 2016
Share This Article
Facebook Twitter Copy Link Print

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Even in Winter, Life Persists in Arctic Seas

(USCGC Healy breaking through the Bering Sea waves. Credit: Chantelle Rose/NSF)   Despite…

A Biodiversity Discovery That Was Waiting in the Wings–Wasp Wings, That Is

Wing size differences between two Nasonia wasp species are the result of…

Entertainement

Coming soon

Your one-stop resource for medical news and education.

Your one-stop resource for medical news and education.
Sign Up for Free

You Might Also Like

Latest News

Researchers develop new robot medics for places doctors are unable to be

By Admin
Latest News

Even thinking about marriage gets young people to straighten up

By admin
Latest News

Study: People tend to locate the self in the brain or the heart – and it affects their judgments and decisions

By admin
Latest News

UCLA patient is first to receive successful heart transplant after using experimental 50cc Total Artificial Heart

By admin
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Editorial Policy
  • Accessibility Statement
  • Contact US
  • Feedback
  • Advertisement
More Info
  • Newsletter
  • Beauty Lab
  • News & Perspective
  • Food & Diet
  • Health
  • Environment
  • Anatomy

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

Copyright © 2023 ScienceAbode. All Rights Reserved. Designed and Developed by Spirelab Solutions (Pvt) Ltd

Welcome Back!

Sign in to your account

Lost your password?